Obstetric antiphospholipid syndrome

Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse obstetric findings like preterm delivery, intrauterine growth restriction, preeclampsia, HELLP syndrome and others. The...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2012

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23166

Acceso en línea:

https://doi.org/10.1016/j.autrev.2011.10.006
https://repository.urosario.edu.co/handle/10336/23166

Palabra clave:

Acetylsalicylic acid
Antibody
Antithrombin
Autoantibody
Beta 2 glycoprotein 1 antibody
Betamethasone
Cardiolipin antibody
Dalteparin
Dexamethasone
Enoxaparin
Heparin
Low molecular weight heparin
Lupus anticoagulant
Nadroparin
Prednisolone
Prednisone
Unclassified drug
Warfarin
Antibody detection
Antiphospholipid syndrome
Autoimmune disease
Human
Hypercoagulability
Laboratory test
Low drug dose
Morbidity
Nonhuman
Preconception injury
Pregnancy
Puerperium
Review
Spontaneous abortion
Standardization
Teratogenicity
Thrombosis
Vascular disease
Animals
Antibody-dependent cell cytotoxicity
Antiphospholipid syndrome
Aspirin
Blood coagulation
Female
Heparin
Humans
Immunotherapy
Individualized medicine
Mice
Pregnancy
Pregnancy complications
Antiphospholipid antibodies
Obstetric antiphospholipid syndrome
Recurrent pregnancy miscarriage
habitual
animal
antiphospholipid
Abortion
Antibodies
Disease models

Rights

License

Abierto (Texto Completo)